1 |
Fujimura M, Funaki T, Houkin K, Takahashi JC, Kuroda S, Tomata Y, et al. : Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease: case-control study of the Japan adult moyamoya trial. J Neurosurg, 2018 [Epub ahead of print]
|
2 |
Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T : Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis 33 : 436-445, 2012
DOI
|
3 |
Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T : Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67 : 273-282, 2007
DOI
|
4 |
Fujimura M, Kaneta T, Shimizu H, Tominaga T : Cerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalo-myo-synangiosis in moyamoya disease. Neurosurg Rev 32 : 245-249, 2009
DOI
|
5 |
Sakata H, Fujimura M, Mugikura S, Sato K, Tominaga T : Local vasogenic edema without cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. J Stroke Cerebrovasc Dis 24 : e179-e184, 2015
DOI
|
6 |
Suzuki J, Takaku A : Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20 : 288-299, 1969
DOI
|
7 |
Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, et al. : Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan adult moyamoya trial. Stroke 47 : 37-43, 2016
DOI
|
8 |
Tashiro R, Fujimura M, Mugikura S, Niizuma K, Endo H, Endo T, et al. : Paradoxical association of symptomatic local vasogenic edema with global cerebral hypoperfusion after direct revascularization surgery for adult moyamoya disease. J Stroke Cerebrlvasc Dis, 2018 [Epub ahead of print]
|
9 |
Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, et al. : Minocycline prevents focal neurologic deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery 74 : 163-170; discussion 170, 2014
DOI
|
10 |
Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T : Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71 : 442-447, 2009
DOI
|
11 |
Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T : Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using Nisopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery 68 : 957-964, 2011
DOI
|
12 |
Fujimura M, Shimizu H, Mugikura S, Tominaga T : Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol 71 : 223-227, 2009
DOI
|
13 |
Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, et al. : Genetics and biomarkers of moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke 16 : 65-72, 2014
DOI
|
14 |
Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K : Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke 47 : 1930-1932, 2016
DOI
|
15 |
Tominaga T, Suzuki N, Miyamoto S, Koizumi A, Kuroda S, Takahashi JC, et al. : Recommendations for the management of moyamoya disease: a statement from research committee on spontaneous occlusion of the circle of Willis (moyamoya disease) [2nd Edition]. Surg Cereb Stroke 46 : 1-24, 2018
DOI
|
16 |
Tu XK, Fujimura M, Rashad S, Mugikura S, Sakata H, Niizuma K, et al. : Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift'. Neurosurg Rev 40 : 507-512, 2017
DOI
|
17 |
Fujimura M, Tominaga T : Current status of revascularization surgery for moyamoya disease: special consideration for its 'internal carotidexternal carotid (IC-EC) conversion' as the physiological reorganization system. Tohoku J Exp Med 236 : 45-53, 2015
DOI
|
18 |
Fujimura M, Tominaga T : Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo) 52 : 327-332, 2012
DOI
|
19 |
Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T : Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol 72 : 476-480, 2009
DOI
|
20 |
Uchino H, Kuroda S, Hirata K, Shiga T, Houkin K, Tamaki N : Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study. Stroke 43 : 2610-2616, 2012
DOI
|
21 |
Yuan M, Liu ZQ, Wang ZQ, Li B, Xu LJ, Xiao XL : High-resolution MR imaging of the arterial wall in moyamoya disease. Neurosci Lett 584 : 77-82, 2015
DOI
|
22 |
Houkin K, Ishikawa T, Yoshimoto T, Abe H : Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg 99 Suppl 2 : S142-S145, 1997
|
23 |
Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. : Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan adult moyamoya trial. J Neurosurg 128 : 777-784, 2018
DOI
|
24 |
Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. : High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease: analysis of a nonsurgical cohort in the Japan adult moyamoya trial. J Neurosurg, 2018 [Epub ahead of print]
|
25 |
Funaki T, Takahashi JC, Yoshida K, Takagi Y, Fushimi Y, Kikuchi T, et al. : Periventricular anastomosis in moyamoya disease: detecting fragile collateral vessels with MR angiography. J Neurosurg 124 : 1766-1772, 2016
DOI
|
26 |
Hayashi K, Horie N, Izumo T, Nagata I : A nationwide survey on unilateral moyamoya disease in Japan. Clin Neurol Neurosurg 124 : 1-5, 2014
DOI
|
27 |
Hayashi T, Shirane R, Fujimura M, Tominaga T : Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr 6 : 73-81, 2010
DOI
|
28 |
Hwang JW, Yang HM, Lee H, Lee HK, Jeon YT, Kim JE, et al. : Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease. Br J Anaesth 110 : 773-779, 2013
DOI
|
29 |
Irikura K, Miyasaka Y, Kurata A, Tanaka R, Fujii K, Yada K, et al. : A source of haemorrhage in adult patients with moyamoya disease: the significance of tributaries from the choroidal artery. Acta Neurochir (Wien) 138 : 1282-1286, 1996
DOI
|
30 |
Kaku Y, Morioka M, Ohmori Y, Kawano T, Kai Y, Fukuoka H, et al. : Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien) 154 : 2151-2157, 2012
DOI
|
31 |
Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. : A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet 56 : 34-40, 2011
DOI
|
32 |
Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, et al. : Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81 : 673-678, 2010
DOI
|
33 |
Kim JE, Oh CW, Kwon OK, Park SQ, Kim SE, Kim YK : Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis 25 : 580-586, 2008
DOI
|
34 |
Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y, Research Committee on Moyamoya Disease in Japan : Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke 38 : 1430-1435, 2007
DOI
|
35 |
Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y : Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36 : 2148-2153, 2005
DOI
|
36 |
Ryoo S, Cha J, Kim SJ, Choi JW, Ki CS, Kim KH, et al. : High-resolution magnetic resonance wall imaging findings of moyamoya disease. Stroke 45 : 2457-2460, 2014
DOI
|
37 |
Kuroda S, Kashiwazaki D, Akioka N, Koh M, Hori E, Nishikata M, et al. : Specific shrinkage of carotid forks in moyamoya disease: a novel key finding for diagnosis. Neurol Med Chir (Tokyo) 55 : 796-804, 2015
DOI
|
38 |
Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, et al. : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the japan adult moyamoya trial. Stroke 45 : 1415-1421, 2014
DOI
|
39 |
Morioka M, Hamada J, Kawano T, Todaka T, Yano S, Kai Y, et al. : Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 34 : 90-95, 2003
DOI
|
40 |
Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases : Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 52 : 245-266, 2012
DOI
|